Moberg Pharma AB
14 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) (NCT05279846) | Moberg Pharma AB | 2022-05-09 |
| A Study of the Systemic Absorption of MOB015B (NCT03244280) | Moberg Pharma AB | 2017-12-16 |
| Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design (NCT06369675) | Moberg Pharma AB | 2017-10-19 |
| Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design (NCT06369727) | Moberg Pharma AB | 2017-10-15 |
Track Moberg Pharma AB automatically
Every clearance here is in the API, with alerts when new ones post.